Red Tortoise LLC Roivant Sciences Ltd. Transaction History
Red Tortoise LLC
- $205 Million
- Q2 2025
A detailed history of Red Tortoise LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Red Tortoise LLC holds 241 shares of ROIV stock, worth $3,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
241
Previous 241
-0.0%
Holding current value
$3,918
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
362Shares Held
456MCall Options Held
8.36MPut Options Held
760K-
Sb Investment Advisers (Uk) LTD London, X060MShares$975 Million5.36% of portfolio
-
Morgan Stanley New York, NY44.7MShares$727 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$639 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$575 Million0.01% of portfolio
-
Viking Global Investors LP34.2MShares$557 Million1.22% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $11.5B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...